Post-refractive IOL Outcomes With Clareon TruPlus
NCT: NCT07610226 · NOT_YET_RECRUITING
Brief Summary
This is a prospective, single-arm, single-center, single-surgeon study evaluating the Clareon TruPlus IOL in post-refractive cataract patients. Subjects will be assessed up to 3 months post-operatively. Clinical evaluations will include refractive outcomes, visual acuity, and administration of the PRISQ Questionnaire.
Frequently Asked Questions
What is Post-refractive IOL Outcomes With Clareon TruPlus?
Post-refractive IOL Outcomes With Clareon TruPlus is a clinical trial registered under NCT07610226. Current status: NOT_YET_RECRUITING.
What is the status of NCT07610226?
The current status of NCT07610226 (Post-refractive IOL Outcomes With Clareon TruPlus) is: NOT_YET_RECRUITING.
When did Post-refractive IOL Outcomes With Clareon TruPlus start?
Post-refractive IOL Outcomes With Clareon TruPlus started on 2026-06-23.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.